Targeting Stroke in Phase 3 Trials by ThinkResearch published on 2019-06-04T20:53:15Z Stroke occurs in about 800,000 U.S. patients each year. Taylor Kimberly, MD, PhD, MGH, discusses his work running a phase 3 clinical trial investigating brain swelling in stroke patients and the challenges associated with running a multisite clinical trial. Genre Science
